Employees Retirement System of Texas’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,018
| Closed | -$782K | – | 571 |
|
|
2022
Q2 | $782K | Hold |
8,018
| – | – | 0.01% | 637 |
|
|
2022
Q1 | $752K | Hold |
8,018
| – | – | 0.01% | 675 |
|
|
2021
Q4 | $683K | Hold |
8,018
| – | – | 0.01% | 695 |
|
|
2021
Q3 | $769K | Hold |
8,018
| – | – | 0.01% | 724 |
|
|
2021
Q2 | $780K | Hold |
8,018
| – | – | 0.01% | 687 |
|
|
2021
Q1 | $780K | Hold |
8,018
| – | – | 0.01% | 691 |
|
|
2020
Q4 | $769K | Hold |
8,018
| – | – | 0.01% | 599 |
|
|
2020
Q3 | $771K | Hold |
8,018
| – | – | 0.01% | 656 |
|
|
2020
Q2 | $978K | Hold |
8,018
| – | – | 0.01% | 645 |
|
|
2020
Q1 | $694K | Sell |
8,018
-32,400
| -80% | -$2.8M | 0.01% | 644 |
|
|
2019
Q4 | $4.35M | Hold |
40,418
| – | – | 0.07% | 325 |
|
|
2019
Q3 | $3.64M | Buy |
+40,418
| New | +$3.64M | 0.06% | 359 |
|